← Leaderboards
Alan B Leichtman
University Of Michigan At Ann Arbor
$472,106
Attributed
$472,106
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
FDA$471,900 · 1
NIH$206 · 3
By mechanism
U01$471,900 · 1
M01$206 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Jonathan S Bromberg$26,279,150
- Friedhelm Hildebrandt$22,945,432
- Weiping Zou$38,970,401
- James K Richardson$3,588,324
- Akinlolu O Ojo$28,267,036
Others in their field
Top investigators on “Kidney Transplantation”
- Peter Scott Heeger · Case Western Reserve University$86,758,000
- Joren C Madsen · Massachusetts General Hospital$51,129,981
- Dorry Segev · Johns Hopkins University$40,143,271
- Peter G Stock · University Of California San Francisco$37,405,503
- Robert M Merion · University Of Michigan At Ann Arbor$29,566,275
- John C Magee · University Of Michigan At Ann Arbor$28,786,531
Research focus
Kidney TransplantationDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationClinical ResearchImmunosuppressivePharmacokineticsSirolimusCombination ChemotherapyDosageClinical Trial Phase IDrug Adverse EffectCyclosporinesPrednisoneAzathioprineArtificial ImmunosuppressionHomologous Transplantation
Grant awards (6)
Transplant Outcomes Using Generic and Brand Name Immunosuppressants: studying medications used by people who have received kidney and liver transplants$471,900
U01 · FY2015 · FD · contact PI
Pharmacokinetic, safety &tolerability of FTY720 in stable renal transplant patie$0
M01 · FY2002 · RR
Efficacy &safety of SDZ RAD immunosuppressive therapy in renal transplants$0
M01 · FY2002 · RR
SIROLIMUS AZATHIOPRINE WITH IMMUNOSUPPRESSIVE THERAPY IN ALLOGRAFT RECIPIENTS$206
M01 · FY2000 · RR
Pharmacokinetic, safety &tolerability of FTY720 in stable renal transplant patie$0
M01 · FY2000 · RR
Efficacy &safety of SDZ RAD immunosuppressive therapy in renal transplants$0
M01 · FY2000 · RR